HS2 Review Blames HighSpeed Design and Political Instability for Cost Overruns Qualcomm Stock Pulls Back as Semiconductor Rally Loses Momentum Canaan CAN Q4 2025 Earnings Miss by Significant Key Takeaways Strategy Inc Raises 2 Billion in Stock Offering Acquires 24869 Bitcoin Delaying Social Security to 67 May Offer Guaranteed 810 Annual Benefit Boost Advisors Suggest Chinese Investors Pivot to Dividend Stocks Amid Limited Investment Options Mortgage Rates Show Mixed Movements as 30Year Fixed Declines and 15Year Rises Hyderabad Police Launches AIPowered Multilingual Complaint App Implications for Public Sector Digitalization Tesla EV Registrations Surge in Europe Stock Approaches Potential Breakout PutinXi Talks Could Revive Stalled Power of Siberia 2 Gas Pipeline as Iran Conflict Shakes Energy Markets Wheeler Real Estate Investment Trust Inc 700 Senior Subordinated Convertible Notes Due 2031 WHLRL Q2 2024 Earnings Strong EPS Amid Limited Guidance COE Q3 2025 Earnings Loss per ADS Reported Stock Edges Higher FirstCash Holdings FCFS Q1 2026 Earnings Strong EPS Beat Driven by Operational Discipline CISO Q2 2025 Earnings EPS of 009 as Shares Decline Energizer Holdings ENR Q1 2026 Earnings Staggering EPS Beat Lifts Shares AVAL Q2 2025 Earnings Strong EPS Report Amid Mixed Macro Signals Donegal Group Inc DGICB Holds Steady at 1895 as Support and Resistance Levels Come into Focus Waterstone Financial Inc WSBF Edges Higher as Shares Hold Above Key Support Offerpad Solutions OPAD Climbs 786 Navigating the 072080 Range Phreesia Inc PHR Holds Steady Near Support Amid Consolidation EVOXW Warrants Hold Steady at 038 Awaiting Catalyst Danaher Edges Lower Amid Consolidation Support and Resistance Levels in Focus Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress PECO Q1 2026 Earnings Strong EPS Beat Driven by Robust Portfolio Performance Corebridge Financial CRBG Q1 2026 Earnings EPS Misses by a Hair Stock Edges Higher BIPC Q1 2026 Earnings Significant EPS Miss Raises Concerns HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Discretion Standard Chartered Targets Higher Returns With Over 15 Reduction in Corporate Functions Roles by 2030 Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Harmony Biosciences HRMY Holds Steady After Modest Gain Support and Resistance in Focus